These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9545022)

  • 1. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
    Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
    Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
    Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
    Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.
    Meeran K; O'Shea D; Edwards CM; Turton MD; Heath MM; Gunn I; Abusnana S; Rossi M; Small CJ; Goldstone AP; Taylor GM; Sunter D; Steere J; Choi SJ; Ghatei MA; Bloom SR
    Endocrinology; 1999 Jan; 140(1):244-50. PubMed ID: 9886831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
    Hayes MR; Bradley L; Grill HJ
    Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.
    Rinaman L
    Am J Physiol; 1999 Nov; 277(5):R1537-40. PubMed ID: 10564228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.
    Donahey JC; van Dijk G; Woods SC; Seeley RJ
    Brain Res; 1998 Jan; 779(1-2):75-83. PubMed ID: 9473596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation.
    Hwa JJ; Ghibaudi L; Williams P; Witten MB; Tedesco R; Strader CD
    Peptides; 1998; 19(5):869-75. PubMed ID: 9663452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats.
    Rinaman L; Rothe EE
    Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R99-106. PubMed ID: 12069935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.
    Thiele TE; Seeley RJ; D'Alessio D; Eng J; Bernstein IL; Woods SC; van Dijk G
    Brain Res; 1998 Aug; 801(1-2):164-70. PubMed ID: 9729361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the brainstem preproglucagon system in the obese Zucker rat.
    Vrang N; Larsen PJ; Jensen PB; Lykkegaard K; Artmann A; Larsen LK; Tang-Christensen M
    Brain Res; 2008 Jan; 1187():116-24. PubMed ID: 18022140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.
    Wang T; Edwards GL; Baile CA
    Proc Soc Exp Biol Med; 1998 Oct; 219(1):85-91. PubMed ID: 9751227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
    Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
    Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide.
    Blázquez E; Alvarez E; Navarro M; Roncero I; Rodríguez-Fonseca F; Chowen JA; Zueco JA
    Mol Neurobiol; 1998 Oct; 18(2):157-73. PubMed ID: 10065878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.
    Kinzig KP; D'Alessio DA; Seeley RJ
    J Neurosci; 2002 Dec; 22(23):10470-6. PubMed ID: 12451146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes.
    Lankat-Buttgereit B; Göke R; Stöckmann F; Jiang J; Fehmann HC; Göke B
    Digestion; 1994; 55(1):29-33. PubMed ID: 8112494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
    Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.